Search results
A Life Expansion Revolution Is Coming: 3 Stocks That Could Lead the Charge | The Motley Fool
The Motley Fool· 2 days agoBy harnessing vast amounts of data and employing sophisticated algorithms, AI could accelerate the...
Charles River (CRL) Partners to Reduce Animal Research Usage
Zacks via Yahoo Finance· 3 days agoEach of them presently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar | The Motley Fool
The Motley Fool· 3 days agoThe S&P 500 rose to a record high earlier this year, confirming its presence in a bull market, and...
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
BioPharma Dive via Yahoo Finance· 7 days agoAfter 34 years, Geron finally has an approved medicine in Rytelo. Elsewhere, Shionogi disclosed...
Meme Mania Meets Medicine: 3 Biotech Stocks Primed to Soar
InvestorPlace· 7 days agoIn a meme frenzy, any positive news related to a company has a magnified impact on the stock price....
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoThe French pharmaceutical company anticipates peak sales of over EUR500 million for its drug marketed as Iqirvo, above RBC’s expectations...CGS-CIMB...
The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash
InvestorPlace via Yahoo Finance· 7 days agoFrom 1930 to 2023, 70% of dividend stocks in the top two quintiles outperformed the S&P 500 during...
These Biotech Stocks Hit New Highs, Did You Reap The Rewards?
RTT News· 7 days agoThe following compilation represents a selection of stocks featured on our website that reached new 52-week high levels during the current week. Protagonist is a clinical-stage biopharmaceutical ...
Questor: Investors are undervaluing this London company’s pubs and hotels
The Telegraph via Yahoo Finance· 3 days agoWe are hopefully not tempting providence by taking a fresh look at Fuller Smith & Turner ahead of...
Goldman Sachs raises Royalty Pharma stock target on deal activity By Investing.com
Investing.com· 7 days agoThe adjustment reflects the latest revenue and future projections for active royalty deals following...